NeuroRegen Scaffold™ With Stem Cells for Chronic Spinal Cord Injury Repair

PHASE1UnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Spinal Cord Injury
Interventions
BIOLOGICAL

NeuroRegen scaffold with BMMCs or MSCs transplantation

Patients with chronic SCI (ASIA grade A) will receive NeuroRegen Scaffold with bone marrow mononuclear cells (BMMCs) or mesenchymal stem cells (MSCs) transplantation after localized scars cleared and after surgery patients will undergo a comprehensive rehabilitation, psychological and nutritional measures.

Trial Locations (3)

100037

First Hospitals affiliated to the China PLA General Hospital, Beijing

215006

The First Affiliated Hospital of Soochow University, Suzhou

300162

Affiliated Hospital of Logistics Universtiy of CAPF, Tianjin

Sponsors
All Listed Sponsors
collaborator

Affiliated Hospital of Logistics University of CAPF

OTHER

collaborator

The First Affiliated Hospital of Soochow University

OTHER

collaborator

First Hospitals affiliated to the China PLA General Hospital

OTHER_GOV

lead

Chinese Academy of Sciences

OTHER_GOV

NCT02352077 - NeuroRegen Scaffold™ With Stem Cells for Chronic Spinal Cord Injury Repair | Biotech Hunter | Biotech Hunter